Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Business Insurance: Reviews of psych claims in comp increase
Requests for independent medical examinations for workers compensation claims with a psychological condition are rising, in part due to great
Five Initial Evaluation Issues That May Delay Return to Work
You only get one chance to make a first impression. This common phrase is especially true in establishing a positive relationship between an injured employee and the treating physician in a workers' compensation case.
Mitchell Announces Launch of Intelligent Estimating Solution
Built leveraging Google's knowledge in machine learning and computer vision, the new solution will produce both guided and automated estimates.
High Impact Drug Class Trends in 2018
Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings.
Five Questions with Assured Research President William Wilt on What’s Trending in Auto and Workers’ Comp Today
We sat down with William Wilt, president of P&C industry research firm Assured Research, to explore what’s trending in the auto casualty and workers’ compensation industry today.
Congress Makes Moves to Weed Out Marijuana Restrictions
After considering several marijuana-related bills, the US House passed HR 1595, the SAFE Banking Act on Wednesday, September 25, 2019.